Return on Investments: An indicator of how profitable a company is relative to its assets invested by shareholders and long-term bond holders. Calculated by dividing a company's operating earnings by its long-term debt and shareholders equity. Calculated as: Income from Continuing Operations / (Total Long-Term Debt + Shareholders Equity)
Alto Neuroscience, Inc. (ANRO) had Return on Investments of -11.80% for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-27.64M |
|
-- |
|
-- |
|
$29.13M |
|
$-29.13M |
|
$1.49M |
|
$-27.64M |
|
$-27.64M |
|
$-27.64M |
|
$-27.64M |
|
$-27.64M |
|
$-27.64M |
|
$-29.13M |
|
$-28.95M |
|
42.81M |
|
42.81M |
|
$-0.65 |
|
$-0.65 |
|
| Balance Sheet Financials | |
$247.32M |
|
$2.05M |
|
$6.75M |
|
$254.07M |
|
$16.65M |
|
$14.88M |
|
$18.16M |
|
$34.82M |
|
$219.25M |
|
$219.25M |
|
$219.25M |
|
35.09M |
|
| Cash Flow Statement Financials | |
$-46.85M |
|
$-0.56M |
|
$114.67M |
|
$176.98M |
|
$244.23M |
|
$67.25M |
|
$6.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.85 |
|
-- |
|
-- |
|
0.06 |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-47.41M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.61% |
|
-12.61% |
|
-10.88% |
|
|
Return on Investments |
-11.80% |
$6.25 |
|
$-1.11 |
|
$-1.09 |
|